COMMUNIQUÉS West-GlobeNewswire

Centrexion Therapeutics Announces Completion of Patient Enrollment in Pivotal Phase 3 Clinical Trial of CNTX-4975 for the Treatment of Moderate to Severe Knee Osteoarthritis Pain

05/12/2018 - 13:30

BOSTON, Dec. 05, 2018 (GLOBE NEWSWIRE) -- Centrexion Therapeutics Corporation, a company focused on developing non-opioid, non-addictive therapeutics for the treatment of chronic pain, today announced completion of [...]

Donald B. Kohn, MD, Orchard Therapeutics Scientific Advisory Board Member, Presents Clinical Proof-of-Concept Data for OTL-102 Gene Therapy for the Treatment of Patients with X-CGD at the Presidential Symposium at the 2018 ASH Annual Meeting

05/12/2018 - 13:30

First demonstration of potential gene therapy treatment in this population leading to sustained levels of functioning neutrophils after 12 months BOSTON and LONDON, Dec. 05, 2018 (GLOBE NEWSWIRE) -- Orchard Therapeutics [...]

Conatus Announces Results from ENCORE-PH Phase 2b Clinical Trial in NASH Cirrhosis

05/12/2018 - 13:30

- Clinically Meaningful Improvements in Portal Hypertension in High Risk Compensated Cirrhosis Patients - - Conference Call and Webcast Presentation at 8:30 a.m. ET Today - SAN DIEGO, Dec. 05, 2018 (GLOBE NEWSWIRE) -- [...]

Cytokinetics Announces Initiation of Phase 1 Clinical Trial of CK-3773274, a Cardiac Myosin Inhibitor

05/12/2018 - 13:30

SOUTH SAN FRANCISCO, Calif., Dec. 05, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the first subject has been dosed in a Phase 1 double-blind, randomized, placebo-controlled, multi- [...]

IMV Welcomes Marc Jasmin as Senior Director, Investor Relations and Communications

05/12/2018 - 13:05

DARTMOUTH, Nova Scotia, Dec. 05, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology corporation, today announced that Marc Jasmin has joined the Company in the newly created role [...]

TATAA Biocenter Expands Its Next-Generation Sequencing Offerings with HTG Molecular Diagnostics' Unique HTG EdgeSeq System

05/12/2018 - 13:00

GÖTEBORG, Sweden and TUSCON, Ariz., Dec. 05, 2018 (GLOBE NEWSWIRE) -- TATAA Biocenter, Europe's leading provider of genomic services, and HTG Molecular Diagnostics, Inc (HTG) (Nasdaq: HTGM), a provider of instruments, [...]

BeiGene Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

05/12/2018 - 13:00

CAMBRIDGE, Mass. and BEIJING, China, Dec. 05, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]

Pam Matthews Brings Management and Operations Experience to New Role at Georgia Health Information Network

05/12/2018 - 13:00

ATLANTA, Dec. 05, 2018 (GLOBE NEWSWIRE) -- Pamela V. (Pam) Matthews, RN, MBA, FHIMSS, CPHIMS, has joined the Georgia Health Information Network (GaHIN) as Executive Operating Officer. GaHIN is a nonprofit organization [...]

Tetraphase Pharmaceuticals to Present at BMO Prescriptions for Success Healthcare Conference

05/12/2018 - 12:30

WATERTOWN, Mass., Dec. 05, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening [...]

Eve & Co Lists on the OTCQB Under Ticker “EEVVF”

05/12/2018 - 12:30

TORONTO, Dec. 05, 2018 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (TSX-V: EVE; OTCQB: EEVVF) (“Eve & Co” or the “Company”) is pleased to announce that its common shares will be listed for trading on the OTCQB [...]

Virbac : Declaration of the number of shares and voting rights as of November 2018, 30.

05/12/2018 - 09:36

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial [...]

Virbac : Déclaration d'actions et de droits de vote au 30 Novembre 2018

05/12/2018 - 09:36

DECLARATION D'ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d'actions composant le capital (Article 223-16 du Règlement Général de l'Autorité des Marchés Financiers) [...]

Rule 2.9 Announcement

05/12/2018 - 08:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 5 December 2018 [...]

PledPharma prepares for listing on the Nasdaq Stockholm main market during 2019

05/12/2018 - 08:00

Stockholm, December 5, 2018. The Board of PledPharma AB (publ) has decided to initiate a process to enable listing of the company's share on Nasdaq Stockholm's main market in 2019. The PledPharma share has been traded [...]

111, Inc. Partners with Manulife-Sinochem to Establish Online Pharmacy + Health Insurance Model

05/12/2018 - 04:30

SHANGHAI, China, Dec. 04, 2018 (GLOBE NEWSWIRE) -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, today announced it has established a strategic partnership [...]

TRACON Pharmaceuticals and I-Mab Biopharma Reschedule Conference Call to Discuss Strategic Partnerships for Multiple Immuno-Oncology Programs

05/12/2018 - 01:00

SAN DIEGO, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Due to the United States stock markets being closed on Wednesday, December 5, 2018, for the national day of mourning due to the passing of President George H. W. Bush, TRACON [...]

Quotient Limited Announces Receipt of Consents to Modifications to the Company’s Senior Secured Notes

04/12/2018 - 23:42

JERSEY, Channel Islands, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced the receipt of consents from the holders of its Senior [...]

Medtronic Announces Worldwide Voluntary Field Corrective Action; Company Issues Software Update for Puritan Bennett(TM) 980 (PB980) Ventilator Series

04/12/2018 - 22:30

DUBLIN - December 4, 2018 - Medtronic (NYSE:MDT) is notifying customers worldwide of a voluntary field corrective action for its Puritan Bennett(TM) 980 (PB980) ventilator series. Medtronic initiated this field action [...]

Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04/12/2018 - 22:30

BURLINGTON, Mass., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced a grant of inducement stock options to five new employees for an aggregate of 24,150 shares of common stock. [...]